Krista A. Zanetti, Ph.D., M.P.H., R.D.
Program Director, Genomic Epidemiology Branch, Epidemiology and Genomics Research Program
- Telephone: (240) 276-6843
- Fax: (240) 276-7920
- E-mail: firstname.lastname@example.org
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E218, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
- 'Omics data integration
- Ph.D. - Nutrition
- M.P.H. - Epidemiologic and Biostatistical Methods for Public Health and Clinical Research
The Johns Hopkins Bloomberg School of Public Health
- B.S. - Clinical Dietetics and Nutrition
University of Pittsburgh
Dr. Krista Zanetti is a Program Director in the Genomic Epidemiology Branch (GEB)—formerly the Host Susceptibility Factors Branch (HSFB)—of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). Her responsibilities include managing a portfolio of grants that includes 'omics (metabolomics, proetomics, and transcriptomics), integration of 'omics data with genomics data, and rare cancers. She is involved in trans-agency and trans-NIH activities that address the use of metabolomics technologies in population-based research to accelerate cancer biomarker discovery. In this capacity, Dr. Zanetti chairs the Trans-Agency Metabolomics and Epidemiology (MetEpi) Working Group and the NIH Metabolomics Scientific Interest Group. She is also the Program Officer for the COnsortium of METabolomics Studies (COMETS) and a member of the NIH Metabolomics Common Fund Working Group.
Prior to joining EGRP, Dr. Zanetti was a Research Fellow in NCI's Laboratory of Human Carcinogenesis (LHC), Center for Cancer Research. Her studies included a Trans-NCI GWAS of lung cancer and smoking phenotypes in African Americans. Dr. Zanetti also explored biological determinants that contribute to cancer health disparities and studied the association of common allele variants with colon cancer risk using the NCI-Maryland Colon Cancer Case-Control Study. Dr. Zanetti first came to NCI as a Cancer Prevention Fellow in LHC.
Zanetti KA, Mette E, Maruvada P, Milner J, Moore SC, Nicastro HL, Ross SA, Sampson JN, Verma M, Su LJ. The future of metabolomic profiling in population-based research: opportunities and challenges. J Anal Bioanal Tech. 2014 5(4), doi: 10.4172/2155-9872.1000203
Haznadar M, Maruvada P, Mette E, Milner J, Moore, SC, Nicastro HL, Sampson JN, Su LJ, Verma M, Zanetti KA. Navigating the road ahead: addressing challenges for use of metabolomics in epidemiology studies. Metabolomics. 2014 April;10(2):176-8.